Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Leong

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|February 6, 2007
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virusPatricia L Mottram, David Leong, Blessing Crimeen-Irwin, et al.
Stem Cells (Dayton, Ohio)|March 22, 2008
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cellsDavid A Rider, Christian Dombrowski, Amber A Sawyer, et al.
ANZ Journal of Surgery|October 13, 2007
Pathology reporting of resected colorectal cancers in New South Wales in 2000Pierre H Chapuis, Charles Chan, Betty P C Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PETLin Li, Fabio Turatti, Desiree Crow, et al.
Bioconjugate Chemistry|March 15, 2011
Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imagingLin Li, Desiree Crow, Fabio Turatti, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory ArthritisIan K Campbell, David Leong, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
BMJ Open|August 29, 2022
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paperShantelle Smith, Margaret Brand, Susan Harden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRsRolf Spirig, Ian K Campbell, Sandra Koernig, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|February 6, 2007
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virusPatricia L Mottram, David Leong, Blessing Crimeen-Irwin, et al.
Stem Cells (Dayton, Ohio)|March 22, 2008
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cellsDavid A Rider, Christian Dombrowski, Amber A Sawyer, et al.
ANZ Journal of Surgery|October 13, 2007
Pathology reporting of resected colorectal cancers in New South Wales in 2000Pierre H Chapuis, Charles Chan, Betty P C Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PETLin Li, Fabio Turatti, Desiree Crow, et al.
Bioconjugate Chemistry|March 15, 2011
Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imagingLin Li, Desiree Crow, Fabio Turatti, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory ArthritisIan K Campbell, David Leong, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
BMJ Open|August 29, 2022
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paperShantelle Smith, Margaret Brand, Susan Harden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRsRolf Spirig, Ian K Campbell, Sandra Koernig, et al.
Pageof 4